874 filings
Page 9 of 44
DEFA14A
c2w xklmkil3gc409
13 May 21
Additional proxy soliciting materials
5:20pm
8-K
iqb5 tw7uo3
13 May 21
Biolase Reports 70% Revenue Growth
4:11pm
DEFA14A
hoi6dn5
4 May 21
Additional proxy soliciting materials
12:00am
8-K
rop7 b4yjatv
25 Mar 21
Departure of Directors or Certain Officers
12:00am
8-K
krmze2vd52ktd 26xtn
25 Mar 21
Biolase Reports 31% Sequential Revenue Growth
12:00am
8-K
5phtce61166l2
17 Mar 21
Departure of Directors or Certain Officers
4:15pm
8-K
pdr4cq1gia08f94
2 Mar 21
Entry into a Material Definitive Agreement
4:15pm
8-K
z1q5c0u j2akizud
23 Feb 21
Departure of Directors or Certain Officers
7:33am
8-K
ysqi59qeix7l53123
10 Feb 21
BIOLASE, Inc. Announces Pricing of $14.4 Million Bought Deal Offering
4:05pm
424B5
x4p8fk6 af
9 Feb 21
Prospectus supplement for primary offering
5:00pm
DEFA14A
iso9x
4 Feb 21
Additional proxy soliciting materials
5:15pm
8-K
3jss gdcnrowksdnna
4 Feb 21
Biolase Regains Compliance with Nasdaq Minimum Bid Price Requirement and Cancels Special Meeting of Stockholders
5:13pm
DEFA14A
65on31kk5pm51f0h7
3 Feb 21
Additional proxy soliciting materials
6:02am
DEFA14A
ngo 9zr6j
1 Feb 21
Additional proxy soliciting materials
6:06am
DEFR14A
hdsdc4ubj2
26 Jan 21
Revised proxy
6:04am
8-K
synu9si568y36wyz
22 Jan 21
Submission of Matters to a Vote of Security Holders
4:22pm
424B3
ue6 q0jdo3
15 Dec 20
Prospectus supplement
11:47am